Byong Seung Cho
Research Subjects
Byong Seung Cho has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Suparuj Lueangarun
Department of Aesthetic Medicine, College of Integrative Medicine Dhurakij Pundit University Bangkok Thailand
4 shared publications - Therdpong Tempark
Department of Pediatrics and Faculty of Medicine at King Chulalongkorn Memorial Hospital at Chulalongkorn University in Bangkok, Thailand
4 shared publications
Latest Publications
- Open Access
- 15 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70115
Achieving Sustained Hair Repigmentation in Poliosis Circumscripta: Retreatment Outcomes Using Exosomes and Fractional Picosecond Laser
- 15 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70115
Open AccessAchieving Sustained Hair Repigmentation in Poliosis Circumscripta: Retreatment Outcomes Using Exosomes and Fractional Picosecond Laser
- Open Access
- 9 July 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (11) , 3791-3794
Rose stem cell‐derived exosomes for hair regeneration enhancement via noninvasive electroporation in androgenetic alopecia
- 9 July 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (11) , 3791-3794
Open AccessRose stem cell‐derived exosomes for hair regeneration enhancement via noninvasive electroporation in androgenetic alopecia
- Open Access
- 3 June 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (10) , 3128-3132
Topical moisturizer with rose stem cell‐derived exosomes (RSCEs) for recalcitrant seborrheic dermatitis: A case report with 6 months of follow‐up
Introduction: Seborrheic dermatitis (SD) poses significant treatment challenges due to its chronic nature and the side effects associated with long‐term use of conventional therapies like topical corticosteroids. In the search for alternative treatments, exosomes, particularly those derived from rose stem cells (RSCEs), offer a promising avenue due to their potential in managing chronic skin conditions.Objective: This case report examines the efficacy of a topical moisturizer containing RSCEs in treating a patient with refractory SD, aiming to provide an alternative treatment pathway.Materials and Methods: A 40‐year‐old male with a long‐standing history of SD, unresponsive to traditional treatments, underwent a novel treatment regimen. This regimen included an initial topical application of 2.5 mL of RSCEs followed by a maintenance phase involving the application of a RSCE‐containing moisturizer. Clinical outcomes were assessed through the Patient's Global Assessment (PGA) and Investigator's Global Assessment (IGA) scores, along with evaluations of scaling and erythema.Results: Remarkable clinical improvement was noted as early as 1‐day post‐treatment, with significant reductions in redness, scaling, and itching. The patient experienced sustained relief throughout the 6‐month follow‐up, with a recurrence in the sixth month that was less severe than previous flare‐ups. This demonstrated not only the efficacy of RSCEs in symptom management but also their potential in extending remission periods.Conclusion: The chronic management of SD can benefit from innovative treatments like the RSCE‐containing moisturizer, as shown in this case report. While the observed outcomes are promising, indicating substantial improvements in skin condition and symptom management, larger controlled studies are necessary to validate the therapeutic potential of exosome‐containing moisturizers fully. This case underscores the need for alternative therapies in SD treatment, highlighting the role of exosomes as a viable option.
- 3 June 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (10) , 3128-3132
Open AccessTopical moisturizer with rose stem cell‐derived exosomes (RSCEs) for recalcitrant seborrheic dermatitis: A case report with 6 months of follow‐up
Introduction: Seborrheic dermatitis (SD) poses significant treatment challenges due to its chronic nature and the side effects associated with long‐term use of conventional therapies like topical corticosteroids. In the search for alternative treatments, exosomes, particularly those derived from rose stem cells (RSCEs), offer a promising avenue due to their potential in managing chronic skin conditions.Objective: This case report examines the efficacy of a topical moisturizer containing RSCEs in treating a patient with refractory SD, aiming to provide an alternative treatment pathway.Materials and Methods: A 40‐year‐old male with a long‐standing history of SD, unresponsive to traditional treatments, underwent a novel treatment regimen. This regimen included an initial topical application of 2.5 mL of RSCEs followed by a maintenance phase involving the application of a RSCE‐containing moisturizer. Clinical outcomes were assessed through the Patient's Global Assessment (PGA) and Investigator's Global Assessment (IGA) scores, along with evaluations of scaling and erythema.Results: Remarkable clinical improvement was noted as early as 1‐day post‐treatment, with significant reductions in redness, scaling, and itching. The patient experienced sustained relief throughout the 6‐month follow‐up, with a recurrence in the sixth month that was less severe than previous flare‐ups. This demonstrated not only the efficacy of RSCEs in symptom management but also their potential in extending remission periods.Conclusion: The chronic management of SD can benefit from innovative treatments like the RSCE‐containing moisturizer, as shown in this case report. While the observed outcomes are promising, indicating substantial improvements in skin condition and symptom management, larger controlled studies are necessary to validate the therapeutic potential of exosome‐containing moisturizers fully. This case underscores the need for alternative therapies in SD treatment, highlighting the role of exosomes as a viable option.
- Open Access
- 28 February 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (6) , 2307-2311
Hair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser
- 28 February 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (6) , 2307-2311
Open AccessHair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser